Login to your account

Username *
Password *
Remember Me

Review | Invasive respiratory fungal infections in COVID-19 critically ill patients.

Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients – Journal of Fungi  

The post Review | Invasive respiratory fungal infections in COVID-19 critically ill patients. appeared first on Links Medicus.

RCT | Tixagevimab-cilgavimab for treatment of patients hospitalized with COVID-19.

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial – The Lancet Respiratory Medicine Commentary: The potential of tixagevimab–cilgavimab for treating hospitalized COVID-19 patients – News Medical Related: Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial […]

The post RCT | Tixagevimab-cilgavimab for treatment of patients hospitalized with COVID-19. appeared first on Links Medicus.

Review | Imaging the acute respiratory distress syndrome: past, present and future.

Imaging the acute respiratory distress syndrome: past, present and future – Intensive Care Medicine   Commentary on Twitter Imaging #ARDS: past, present & future➡️ physiopathology➡️ management: PEEP/recruitment; inflation (& hyperinfation)➡️ effects of proning on ventilation/perfusion➡️ lung infammation➡️ #COVID19➡️ identifying complications➡️ prognostication& more!? https://t.co/tEp50muK8J pic.twitter.com/GlME1vTePh — Intensive Care Medicine (@yourICM) July 14, 2022  

The post Review | Imaging the acute respiratory distress syndrome: past, present and future. appeared first on Links Medicus.

Systematic Review | Anti‐IL‐5 therapies for asthma.

Anti‐IL‐5 therapies for asthma – Cochrane Library Summary: Mepolizumab, reslizumab or benralizumab for people already taking inhaled steroids and long-acting beta 2-agonists for their asthma – Cochrane Library  

The post Systematic Review | Anti‐IL‐5 therapies for asthma. appeared first on Links Medicus.

What cardiologists should know about sleep.

What cardiologists should know about sleep – European Heart Journal (free for a limited period)  

The post What cardiologists should know about sleep. appeared first on Links Medicus.

AHA Science Advisory | Elucidating the clinical implications and pathophysiology of pulmonary hypertension in heart failure with preserved ejection fraction: a call to action.

Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association – Circulation  

The post AHA Science Advisory | Elucidating the clinical implications and pathophysiology of pulmonary hypertension in heart failure with preserved ejection fraction: a call to action. appeared first on Links Medicus.

M-A | Home oxygen for moderate hypoxemia in chronic obstructive pulmonary disease.

Home oxygen for moderate hypoxaemia in chronic obstructive pulmonary disease: a systematic review and meta-analysis – The Lancet Respiratory Medicine (link to abstract – $ for full-text)   Commentary on Twitter Home oxygen probably makes little or no difference to 3-year mortality in pts with #COPD and moderate hypoxaemia Systematic review & meta-analysis from Yves […]

The post M-A | Home oxygen for moderate hypoxemia in chronic obstructive pulmonary disease. appeared first on Links Medicus.

RCT | Efficacy and safety of Elexacaftor/Tezacaftor/Ivacaftor in children 6 through 11 years of age with cystic fibrosis heterozygous for F508del and a minimal function mutation.

Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3B, Randomized, Placebo-Controlled Study – American Journal of Respiratory and Critical Care Medicine (link to abstract – $ for full-text)  

The post RCT | Efficacy and safety of Elexacaftor/Tezacaftor/Ivacaftor in children 6 through 11 years of age with cystic fibrosis heterozygous for F508del and a minimal function mutation. appeared first on Links Medicus.

M-A | Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2.

Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An updated systematic review and meta-analysis with meta-regression analyzing influencing factors – PLOS Medicine Related: Interpreting a lateral flow SARS-CoV-2 antigen test – The BMJ Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection – Cochrane Library  

The post M-A | Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2. appeared first on Links Medicus.

New coronavirus mutant (BA.2.75) raises concerns in India and beyond.

New coronavirus mutant raises concerns in India and beyond – Associated Press  

The post New coronavirus mutant (BA.2.75) raises concerns in India and beyond. appeared first on Links Medicus.

Recherche